Rare diseases
Investigational molecules
Locations
Back to Poland302 clinical trials in Olsztyn, Poland across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
PolandStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
PolandStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
PolandStudy on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials
PolandStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
PolandStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
PolandAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
PolandA study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
PolandEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
PolandEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
PolandSafety and Tolerability of Alisertib Sodium and Paclitaxel in Patients with Small Cell Lung Cancer (Phase 2 Study)
PolandPhase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA
PolandThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on acute myeloid leukemia treatments and innovative therapies for various types of lung cancer. Studies include evaluation of new drug combinations and treatment approaches for colorectal cancer and lymphoma.
Research emphasizes personalized medicine approaches and improving patient outcomes in advanced stages of disease.
Innovative research into plaque psoriasis and psoriatic arthritis treatments, including new biological therapies and novel drug combinations. Studies also examine treatments for rare conditions like pyoderma gangrenosum.
Focus on developing more effective treatments for moderate to severe skin conditions.
Studies examining new approaches to heart failure prevention and treatment, including investigations of novel drug combinations. Research focuses on reducing cardiovascular events and improving outcomes in high-risk patients.
Emphasis on preventive measures and innovative treatment strategies for cardiac conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
